rabeprazole has been researched along with Angiogenesis, Pathologic in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miao, ZH | 1 |
| Feng, JM | 1 |
| Ding, J | 1 |
1 review available for rabeprazole and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Newly discovered angiogenesis inhibitors and their mechanisms of action.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Diterpenes; Drug Design; Drug Resistance, N | 2012 |